Hospital Costs and Inpatient Mortality among Children Undergoing Surgery for Congenital Heart Disease
Article first published online: 21 OCT 2013
© Health Research and Educational Trust
Health Services Research
Volume 49, Issue 2, pages 588–608, April 2014
How to Cite
Romley, J. A., Chen, A. Y., Goldman, D. P. and Williams, R. (2014), Hospital Costs and Inpatient Mortality among Children Undergoing Surgery for Congenital Heart Disease. Health Services Research, 49: 588–608. doi: 10.1111/1475-6773.12120
- Issue published online: 27 MAR 2014
- Article first published online: 21 OCT 2013
- Manuscript Accepted: 22 JUL 2013
- National Institute on Aging. Grant Number: 1R03AG31990-A1
- Schaeffer Center for Health Policy and Economics
- Health care costs;
- health policy;
- quality of care;
- geographic variation;
- acute inpatient care
To determine the association between hospital costs and risk-adjusted inpatient mortality among children undergoing surgery for congenital heart disease (CHD) in U.S. acute-care hospitals.
Data Sources/Study Settings
Retrospective cohort study of 35,446 children in 2003, 2006, and 2009 Kids' Inpatient Database (KID).
Cross-sectional logistic regression of risk-adjusted inpatient mortality and hospital costs, adjusting for a variety of patient-, hospital-, and community-level confounders.
Data Collection/Extraction Methods
We identified relevant discharges in the KID using the AHRQ Pediatric Quality Indicator for pediatric heart surgery mortality, and linked these records to hospital characteristics from American Hospital Association Surveys and community characteristics from the Census.
Children undergoing CHD surgery in higher cost hospitals had lower risk-adjusted inpatient mortality (p = .002). An increase from the 25th percentile of treatment costs to the 75th percentile was associated with a 13.6 percent reduction in risk-adjusted mortality.
Greater hospital costs are associated with lower risk-adjusted inpatient mortality for children undergoing CHD surgery. The specific mechanisms by which greater costs improve mortality merit further exploration.